Literature DB >> 11781375

IL-17: prototype member of an emerging cytokine family.

Sudeepta Aggarwal1, Austin L Gurney.   

Abstract

IL-17 is a potent proinflammatory cytokine produced by activated memory T cells. The large-scale sequencing of the human and other vertebrate genomes has revealed the presence of additional genes encoding proteins clearly related to IL-17, thus defining a new family of cytokines. There are at least six members of the IL-17 family in humans and in mice. Initial characterization suggests that like IL-17, several of these newly identified molecules have the ability to modulate immune function. Neither the IL-17 family nor the cognate receptors that have been identified for these molecules bear obvious sequence similarity to other known families of proteins. Thus, they represent a distinct signaling system that appears to have been highly conserved across vertebrate evolution. The potent inflammatory actions that have been identified for several of these factors and the emerging associations with major human diseases suggest that these proteins may have significant roles in inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781375

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  177 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.

Authors:  Xuesong Qian; Huan Ning; Jidong Zhang; Daniel F Hoft; Deborah J Stumpo; Perry J Blackshear; Jianguo Liu
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

3.  TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.

Authors:  Sergey V Novitskiy; Michael W Pickup; Agnieszka E Gorska; Philip Owens; Anna Chytil; Mary Aakre; Huiyun Wu; Yu Shyr; Harold L Moses
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

Review 4.  The amphioxus genome provides unique insight into the evolution of immunity.

Authors:  Larry J Dishaw; Robert N Haire; Gary W Litman
Journal:  Brief Funct Genomics       Date:  2012-03-07       Impact factor: 4.241

5.  Detection of autoantibodies and increased concentrations of interleukins in plasma from patients with Tourette's syndrome.

Authors:  Yu-hang Cheng; Yi Zheng; Fan He; Jian-hong Yang; Wen-biao Li; Min-ling Wang; De-yan Cui; Ying Chen
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

Review 6.  Up for Mischief? IL-17/Th17 in the tumour microenvironment.

Authors:  E Maniati; R Soper; T Hagemann
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

7.  SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.

Authors:  Reiko M Onishi; Sangmi J Park; Walter Hanel; Allen W Ho; Amarnath Maitra; Sarah L Gaffen
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 8.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

9.  Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.

Authors:  Haseeb Ilias Basha; Sabarinathan Ramachandran; Venkataswarup Tiriveedhi; Masashi Takenaka; Vijay Subramanian; Dilip S Nath; Nicholas Benshoff; G Alec Patterson; Thalachallour Mohanakumar
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

10.  IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling.

Authors:  Zhili Rong; Anan Wang; Zhiyong Li; Yongming Ren; Long Cheng; Yinghua Li; Yinyin Wang; Fangli Ren; Xiaoning Zhang; Jim Hu; Zhijie Chang
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.